dc.contributor.author |
Iwu, Chinwe Juliana
|
|
dc.contributor.author |
Jordan, Portia
|
|
dc.contributor.author |
Jaja, Ishmael Festus
|
|
dc.contributor.author |
Iwu, Chidozie Declan
|
|
dc.contributor.author |
Wiysonge, Charles Shey
|
|
dc.date.accessioned |
2021-07-15T11:51:04Z |
|
dc.date.available |
2021-07-15T11:51:04Z |
|
dc.date.issued |
2020-07-20 |
|
dc.description.abstract |
There is currently no approved pharmaceutical product for the treatment
of COVID-19. However, antibiotics are currently being used for the
management of COVID-19 patients in many settings either treat to coinfections
or for the treatment of COVID-19 itself. In this commentary,
we highlight that the increased rates of antimicrobial prescribing for
COVID-19 patients could further worsen the burden of antimicrobial
resistance (AMR). We also highlight that though AMR is a global threat,
Africa tends to suffer most from the consequences. We, therefore, call
on African countries not to lose sight of the possible implications of the
treatment of COVID-19 on AMR and a need to redouble efforts towards
the fight against AMR while dealing with the pandemic. |
en_ZA |
dc.description.department |
School of Health Systems and Public Health (SHSPH) |
en_ZA |
dc.description.librarian |
am2021 |
en_ZA |
dc.description.uri |
http://www.panafrican-med-journal.com |
en_ZA |
dc.identifier.citation |
Iwu, C.J., Jordan, P., Jaja, I.F., Iwu, C.D. Treatment of COVID-19: implications for antimicrobial resistance in Africa. Pan Africa Medical Journal. 2020;35(2):119 DOI: 10.11604/pamj.supp.2020.35.23713. |
en_ZA |
dc.identifier.issn |
1937-8688 (online) |
|
dc.identifier.other |
10.11604/pamj.supp.2020.35.23713 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/80864 |
|
dc.language.iso |
en |
en_ZA |
dc.publisher |
African Field Epidemiology Network |
en_ZA |
dc.rights |
© Chinwe Juliana Iwu et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons
Attribution International 4.0 License. |
en_ZA |
dc.subject |
Africa |
en_ZA |
dc.subject |
COVID-19 pandemic |
en_ZA |
dc.subject |
Coronavirus disease 2019 (COVID-19) |
en_ZA |
dc.subject |
Antimicrobial resistance (AMR) |
en_ZA |
dc.subject |
Treatment |
en_ZA |
dc.title |
Treatment of COVID-19 : implications for antimicrobial resistance in Africa |
en_ZA |
dc.type |
Article |
en_ZA |